Preliminary studies point out conolidine may well inhibit distinct ion channels, minimizing neuronal excitability and restricting ache alerts. This system is particularly suitable in neuropathic soreness, the place irregular signaling leads to persistent distress. On top of that, conolidine seems to affect G protein-coupled receptor (GPCR) pathways